Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Kintz Samuel Create: Alert

All | News | Filings
Date FiledTypeDescription
09/26/2023 4 Kintz Samuel (President and CEO) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Sold 12,000 shares @ $13.8076, valued at $165.7k
Exercised 12,000 options to buy @ $1.12, valued at $13.4k
02/27/2023 4 Kintz Samuel (President and CEO) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 1,087,525 shares @ $0
Granted 88,531 shares @ $0
Granted 88,531 shares @ $0
Granted 344,550 options to buy @ $1.12, valued at $385.9k
Granted 404,363 options to buy @ $2.48, valued at $1M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy